Literature DB >> 10811633

Telomerase activity reconstituted in vitro with purified human telomerase reverse transcriptase and human telomerase RNA component.

K Masutomi1, S Kaneko, N Hayashi, T Yamashita, Y Shirota, K Kobayashi, S Murakami.   

Abstract

Telomerase is a specialized reverse transcriptase that catalyzes elongation of the telomeric tandem repeat, TTAGGG, by addition of this sequence to the ends of existing telomeres. Human telomerase reverse transcriptase (hTERT) has been identified as a catalytic enzyme involved in telomere elongation that requires telomerase RNA, human telomerase RNA component (hTR), as an RNA template. We established a new method to express and purify soluble insect-expressed recombinant hTERT. The partially purified FLAG-hTERT retained the catalytic activity of telomerase in a complementation assay in vitro to exhibit telomerase activity in telomerase-negative TIG3 cell extract and in a reconstitution assay with FLAG-hTERT and purified hTR in vitro. FLAG-hTERT (D712A) with a mutation in the VDV motif exhibited no telomerase activity, confirming the authentic catalytic activity of FLAG-hTERT. The reconstituted complex of FLAG-hTERT and hTR in vitro was detected by electrophoretic mobility shift assay, and its activity was stimulated by more than 30-fold by TIG3 cell extract. This suggested that some cellular component(s) in the extract facilitated the reconstituted telomerase activity in vitro. Geldanamycin had no effect on the reconstituted activity but partially reduced the stimulated activity of the reconstituted telomerase by the TIG3 cell extract, suggesting that Hsp90 may contribute to the stimulatory effect of the cellular components.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10811633     DOI: 10.1074/jbc.M000622200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

Review 1.  Natural and pharmacological regulation of telomerase.

Authors:  Jean-Louis Mergny; Jean-François Riou; Patrick Mailliet; Marie-Paule Teulade-Fichou; Eric Gilson
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

2.  A human telomerase-associated nuclease.

Authors:  Rena Oulton; Lea Harrington
Journal:  Mol Biol Cell       Date:  2004-04-30       Impact factor: 4.138

3.  Soluble domains of telomerase reverse transcriptase identified by high-throughput screening.

Authors:  Steven A Jacobs; Elaine R Podell; Deborah S Wuttke; Thomas R Cech
Journal:  Protein Sci       Date:  2005-08       Impact factor: 6.725

4.  Human telomerase contains two cooperating telomerase RNA molecules.

Authors:  C Wenz; B Enenkel; M Amacker; C Kelleher; K Damm; J Lingner
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

5.  Functional regions of human telomerase reverse transcriptase and human telomerase RNA required for telomerase activity and RNA-protein interactions.

Authors:  F Bachand; C Autexier
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

6.  Telomerase trafficking and assembly in Xenopus oocytes.

Authors:  Zhu-Hong Li; Rebecca L Tomlinson; Rebecca M Terns; Michael P Terns
Journal:  J Cell Sci       Date:  2010-07-15       Impact factor: 5.285

7.  Tetrahymena proteins p80 and p95 are not core telomerase components.

Authors:  D X Mason; C Autexier; C W Greider
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-09       Impact factor: 11.205

8.  N-terminal domains of the human telomerase catalytic subunit required for enzyme activity in vivo.

Authors:  B N Armbruster; S S Banik; C Guo; A C Smith; C M Counter
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

9.  Significance of immunological detection of human telomerase reverse transcriptase: re-evaluation of expression and localization of human telomerase reverse transcriptase.

Authors:  Satoru Kyo; Kenkichi Masutomi; Yoshiko Maida; Taro Kanaya; Noriyuki Yatabe; Mitsuhiro Nakamura; Masaaki Tanaka; Mitsuko Takarada; Isamu Sugawara; Seishi Murakami; Takahiro Taira; Masaki Inoue
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

10.  The N-terminus of hTERT contains a DNA-binding domain and is required for telomerase activity and cellular immortalization.

Authors:  David C F Sealey; Le Zheng; Michael A S Taboski; Jennifer Cruickshank; Mitsuhiko Ikura; Lea A Harrington
Journal:  Nucleic Acids Res       Date:  2009-12-23       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.